コンテンツへスキップ
Merck
  • A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.

A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.

Genome biology (2020-05-10)
Andrew J Gentles, Angela Bik-Yu Hui, Weiguo Feng, Armon Azizi, Ramesh V Nair, Gina Bouchard, David A Knowles, Alice Yu, Youngtae Jeong, Alborz Bejnood, Erna Forgó, Sushama Varma, Yue Xu, Amanda Kuong, Viswam S Nair, Rob West, Matt van de Rijn, Chuong D Hoang, Maximilian Diehn, Sylvia K Plevritis
要旨

Tumors comprise a complex microenvironment of interacting malignant and stromal cell types. Much of our understanding of the tumor microenvironment comes from in vitro studies isolating the interactions between malignant cells and a single stromal cell type, often along a single pathway. To develop a deeper understanding of the interactions between cells within human lung tumors, we perform RNA-seq profiling of flow-sorted malignant cells, endothelial cells, immune cells, fibroblasts, and bulk cells from freshly resected human primary non-small-cell lung tumors. We map the cell-specific differential expression of prognostically associated secreted factors and cell surface genes, and computationally reconstruct cross-talk between these cell types to generate a novel resource called the Lung Tumor Microenvironment Interactome (LTMI). Using this resource, we identify and validate a prognostically unfavorable influence of Gremlin-1 production by fibroblasts on proliferation of malignant lung adenocarcinoma cells. We also find a prognostically favorable association between infiltration of mast cells and less aggressive tumor cell behavior. These results illustrate the utility of the LTMI as a resource for generating hypotheses concerning tumor-microenvironment interactions that may have prognostic and therapeutic relevance.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
Anti-Tryptase Antibody, Mast Cell, clone G3, clone G3, Chemicon®, from mouse